According to Soleno Therapeutics, the FDA required more time to review responses to recent information requests. The FDA has extended the review period for the NDA for DCCR tablets for the treatment ...
Asian American, Native Hawaiian, and Pacific Islander (AANHPI) patients with early-stage hepatocellular carcinoma (HCC) have significantly better survival outcomes compared with non-Hispanic White ...
HealthDay News — More than half of all U.S. adults are eligible for semaglutide therapy, according to a research letter published online Nov. 18 in JAMA Cardiology to coincide with the American Heart ...